Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy

Stopped early

Conditions studied: Stargardt Disease, Diabetic Retinopathy, Macular Degeneration (Age Related)

In brief

In this study, markers of oxidative stress will be measured in the aqueous humour of stargardt disease, age related macular degeneration and diabetic retinopathy patients compared to controls.

Key facts

Study ID

NCT02875704

Run by

Johns Hopkins University

People needed

77

Starts

2017-01-03

Expected to finish

2022-09-22

Last updated by the study team

2022-09-26

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed informed consent and authorization of use and disclosure of protected health information
• Age at least 18 years
• For the study group, patients diagnosed with Stargardt disease, age related macular degeneration and diabetic retinopathy by the investigators, based on clinical phenotype
• For the control group, patients with no retinal disease undergoing cataract surgery will be eligible.

You may not qualify if…

• None

Where it is running

• Wilmer Eye Institute — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.